Libros de la coleccion European studies in Lawand economics. Intersentia Ltd.

Utilice este formulario para refinar su búsqueda.

Titulo:

Autor:

Palabras clave:

Editorial:

desde:

hasta:

Mostrando libros encontrados. 1 páginas.

Towards a better assessment of pain and suffering damages for personal injury litigation

a proposal based on quality adjusted life years

Karapanou, Vaia
Intersentia Ltd.. Cambridge, 2014

The assessment of non-economic damages associated with personal injury remains a daunting task for courts. It is the subject of a longstanding and unresolved debate in legal scholarship, as it involves an evaluation of the impact of the immaterial loss incurred, for which a satisfactory ...

91,95 €

Sin Stock. Disponible en 5/6 semanas.

91,95 €

Sin Stock. Disponible en 5/6 semanas.

Towards a better assessment of pain and suffering damages for personal injury litigation

a proposal based on quality adjusted life years

Karapanou, Vaia
Intersentia Ltd.. Cambridge, 2014

The assessment of non-economic damages associated with personal injury remains a daunting task for courts. It is the subject of a longstanding and unresolved debate in legal scholarship, as it involves an evaluation of the impact of the immaterial loss incurred, for which a satisfactory ...

Competition and innovation in the EU regulation of pharmaceuticals

the case of parallel trade

Desogus, Claudia
Intersentia Ltd.. Antwerp, 2011

This book deals with parallel trade of pharmaceuticals from a Law & Economics perspective. Traditionally, restrictions to parallel trade were regarded negatively because they ran against the rules of the EU internal market. However, in recent judgments (Bayer, Glaxo and Syfait), EU Courts questioned some of ...

96,32 €

Sin Stock. Disponible en 5/6 semanas.

96,32 €

Sin Stock. Disponible en 5/6 semanas.

Competition and innovation in the EU regulation of pharmaceuticals

the case of parallel trade

Desogus, Claudia
Intersentia Ltd.. Antwerp, 2011

This book deals with parallel trade of pharmaceuticals from a Law & Economics perspective. Traditionally, restrictions to parallel trade were regarded negatively because they ran against the rules of the EU internal market. However, in recent judgments (Bayer, Glaxo and Syfait), EU Courts questioned some of ...